What is CALC's P/E ratio?

Calcimedica, Inc. Common Stock (CALC) currently trades at a P/E ratio of 3.17.

Calcimedica, Inc. Common Stock reports a Return on Equity (ROE) of 1,770.29%.

What is CALC's dividend yield?

Calcimedica, Inc. Common Stock offers a dividend yield of 0.00%.

What is CALC's Quality Score?

Our AI rates CALC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CALC?

Our AI Timing Score for CALC is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CALC belong to?

Calcimedica, Inc. Common Stock is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Calcimedica, Inc. (CALC) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

CALC AI Analysis Summary

Our AI summary for CALC: Calcimedica, Inc. Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 3.17, ROE of 1,770.29%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CALC

Calcimedica, Inc. Common Stock

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 0.75

-0.25 (-24.73%) Day Change

Watchlist Portfolio Compare Chart

3.17

P/E

-3.80

D/E

1,770.3%

ROE

-227.0%

ROA

0.00%

Div Yield

-0.07

PEG

CALCIMEDICA, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.75 Price -0.25 (-24.73%) Day Change	NEWS SCORE: 98

CALC, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.75
PBV / Sector	-14.31 / 44,219.29
Earning Per Share	-0.93

PE / Sector	3.17 / 19.28 GREAT
PEG or PE/Growth / Sector	-0.07 / 1.23
Average 1M Daily Value	0.27 M GREAT
Average 1W Daily Value	0.39 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.22
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-227.02 / 185,260.96
ROA Average (%) / Sector	-205.87 / 36,684.70
ROA Change Average (%) / Sector	40.97 / 422,221.66 GREAT
ROE (%) / Sector	1,770.29 / 243,762.23
ROE Average (%) / Sector	356.78 / 48,758.47 GREAT
ROE Change Average (%) / Sector	-236.25 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

Registration Details

Analyze Date	2026-08-04 08:01:17
Symbol	CALC
Name	CALCIMEDICA, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	15.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	15.80 / 9,645.64

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 505 Coast Boulevard South, La Jolla, CA, United States, 92037

Phone: 858 952 5500

Website: https://calcimedica.com

Sector: Healthcare >> Biotechnology

Description: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.